These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 9723354)

  • 1. Tacrolimus to cyclosporine microemulsion formulation conversion in the pediatric liver transplant patient.
    Falkenstein K; Dunn S
    Transplant Proc; 1998 Aug; 30(5):1964-6. PubMed ID: 9723354
    [No Abstract]   [Full Text] [Related]  

  • 2. Conversion from tacrolimus to microemulsion formulation of cyclosporine in pediatric liver transplantation.
    Alberti D; Reding R; Otte JB; Falchetti D; Rigamonti W; Caccia G; Sokal E; de Ville de Goyet J
    Transplant Proc; 1998 Aug; 30(5):1858-60. PubMed ID: 9723310
    [No Abstract]   [Full Text] [Related]  

  • 3. Disappearance of diabetes mellitus after conversion from FK 506 to Neoral in two liver transplanted patients.
    Lagget M; Marzano A; Actis GC; Leone N; Ciancio A; Salizzoni M; Rizzetto M
    Transplant Proc; 1998 Aug; 30(5):1863-4. PubMed ID: 9723312
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetics of a microemulsion formulation of cyclosporine in pediatric liver transplant recipients.
    Cooney GF; Lum BL; Meligeni JA; Dunn SP
    Transplant Proc; 1996 Aug; 28(4):2270-2. PubMed ID: 8769222
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclosporine conversion from conventional to microemulsion formulation: effect on renal concentration ability in stable hepatic transplant recipients.
    Fernandez-Fresnedo G; Escallada R; Casafont F; Fábrega E; de Cos MA; Rodrigo E; Cobo M; Cotorruelo JG; Pons F; Arias M
    Transplant Proc; 1997; 29(1-2):547-8. PubMed ID: 9123123
    [No Abstract]   [Full Text] [Related]  

  • 6. Tacrolimus versus cyclosporin microemulsion in liver transplantation: results of a 3-month study.
    Mühlbacher F;
    Transplant Proc; 2001; 33(1-2):1339-40. PubMed ID: 11267317
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of tacrolimus-related adverse effects by conversion to cyclosporine in liver transplant recipients.
    Emre S; Genyk Y; Schluger LK; Fishbein TM; Guy SR; Sheiner PA; Schwartz ME; Miller CM
    Transpl Int; 2000; 13(1):73-8. PubMed ID: 10743694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporine versus cyclosporine microemulsion in pediatric liver transplant recipients.
    Loss GE; Brady L; Grewal HP; Siegel CT; Mead J; Bruce DS; Cronin DC; Woodle ES; Newell KA; Thistlethwaite JR; Millis JM
    Transplant Proc; 1998 Jun; 30(4):1435-6. PubMed ID: 9636581
    [No Abstract]   [Full Text] [Related]  

  • 9. Conversion from tacrolimus to cyclosporine microemulsion therapy in liver transplant recipients.
    Ogino S; Hashikura Y; Katsuyama Y; Ikegami T; Nakazawa Y; Urata K; Terada M; Miyagawa S; Kawasaki S
    Transplant Proc; 2004 Mar; 36(2 Suppl):299S-301S. PubMed ID: 15041357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single-centre experience with cyclosporine microemulsion versus tacrolimus in 100 randomized liver transplant recipients: midterm efficacy and safety.
    Loinaz C; Marin LM; González-Pinto I; Gómez R; Jiménez C; Moreno E
    Transplant Proc; 2001; 33(7-8):3439-41. PubMed ID: 11750472
    [No Abstract]   [Full Text] [Related]  

  • 11. Frequency of switch from cyclosporine to FK 506 before and after Neoral use in pediatric liver transplantation.
    Gridelli B; Colledan M; Lucianetti A; Ulla L; Riva S; Segalin A; Fassati LR; Torre G
    Transplant Proc; 1998 Aug; 30(5):1861-2. PubMed ID: 9723311
    [No Abstract]   [Full Text] [Related]  

  • 12. Microemulsion cyclosporine with C2 monitoring and tacrolimus in liver transplantation with or without hepatitis C virus infection.
    Jain A
    Liver Transpl; 2006 Oct; 12(10):1452-4. PubMed ID: 17004248
    [No Abstract]   [Full Text] [Related]  

  • 13. Conversion and pharmacokinetic studies of a microemulsion formulation of cyclosporine in pediatric liver transplant patients.
    D'Agostino D; Gimenez M; Yamaguchi B; Glancszpigel R; Vinuesa F; Gamba M; Ciardullo M; de Santibaes E
    Transplantation; 1996 Oct; 62(8):1068-71. PubMed ID: 8900303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful reconversion from tacrolimus to cyclosporine A Neoral in pediatric liver recipients.
    Melter M; Rodeck B; Kardorff R; Hoyer PF; Maibücher A; Brodehl J
    Transplant Proc; 1996 Aug; 28(4):2276-8. PubMed ID: 8769224
    [No Abstract]   [Full Text] [Related]  

  • 15. Area under the concentration curve values in pediatric liver transplant recipients on cyclosporin microemulsion formulation.
    Dunn SP; Kulinsky A; Falkenstein K; Pierson A; Chang CT; Cooney GF
    Transplant Proc; 1998 Aug; 30(5):1678-9. PubMed ID: 9723240
    [No Abstract]   [Full Text] [Related]  

  • 16. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
    Levy G; Grazi GL; Sanjuan F; Wu Y; Mühlbacher F; Samuel D; Friman S; Jones R; Cantisani G; Villamil F; Cillo U; Clavien PA; Klintmalm G; Otto G; Pollard S; McCormick PA
    Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of conversion from Sandimmune to Neoral in stable pediatric liver transplant recipients after two years.
    Dunn SP; Falkenstein K; Pierson A; Cooney GF
    Transplant Proc; 1998 Aug; 30(5):1962-3. PubMed ID: 9723353
    [No Abstract]   [Full Text] [Related]  

  • 18. Conversion from the conventional cyclosporine formulation (Sandimmune) to a new oral microemulsion (Neoral) in stable liver transplant patients.
    Dibo-Cohen JM; Conort O; Conti F; Bernard D; Hazebroucq G; Calmus Y
    Transplant Proc; 1998 Aug; 30(5):1857. PubMed ID: 9723309
    [No Abstract]   [Full Text] [Related]  

  • 19. Microemulsion cyclosporine (Neoral) immunosuppression for orthotopic liver transplantation in children reduces hospital stay.
    Arumugam R; Soriano HE; Scheimann AO; Reid BS; Gopalakrishna GS; Barakat O; Ozaki CF; Wood RP
    Transplant Proc; 1998 Aug; 30(5):1848-9. PubMed ID: 9723304
    [No Abstract]   [Full Text] [Related]  

  • 20. Potential role of Neoral in pediatric liver transplantation.
    Whitington PF; Alonso EM; Millis JM
    Transplant Proc; 1996 Aug; 28(4):2267-9. PubMed ID: 8769221
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.